3Kgw SJ, Yen C J, Huang WT, et al. Preemptive of interferon or lami,rudine for hcpatitis B reactiVation in patients with aggressive lymphoma receiving chemotherapy. AnnHemat,2004,83:270-275.
4Liao CA, Lee CM, Wu HC, et al. Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non - Hodgkin' s lymphoma [ J ]. Br J Haematol, 2002, 116 : 166 - 169.
5Leaw SJ, Yen C J, Huang WT, et al. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy [ J ]. Ann Hematol,2004,83:270 - 275.
6Lim LL,Wai CT, Lee YM, et al. Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients [ J ]. Aliment Pharmacol Ther,2002,16 : 1939 - 1944.
7Nagamatsu H, Itano S, Nagaoka S, et al. Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy [ J ]. Am J Gastroenterol,2004 ,99 :2369 - 2375.
8Liaw YF, Leung NW,Chang TT, et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B [ J ]. Gastroenterology,2000,119 : 172 - 180.
